Atlas Trials

Recurrent Kaposi Sarcoma

8 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Recurrent Kaposi Sarcoma

RecordFirmDate
Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV (NCT04514484)National Cancer Institute (NCI)2021-11-22
Nelfinavir Mesylate in Treating Patients With Kaposi Sarcoma (NCT03077451)AIDS Malignancy Consortium2017-03-13
Gamma Secretase Inhibitor PF-03084014 in Treating Patients With AIDS-Associated Kaposi Sarcoma (NCT02137564)AIDS Malignancy Consortium2015-07-01
Lenalidomide in Treating Patients With AIDS-Associated Kaposi's Sarcoma (NCT01057121)National Cancer Institute (NCI)2010-08-27
Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma (NCT01154452)National Cancer Institute (NCI)2010-06-01
Bortezomib in Treating Patients With Relapsed or Refractory AIDS-Related Kaposi Sarcoma (NCT01016730)National Cancer Institute (NCI)2010-01-22
Halofuginone Hydrobromide in Treating Patients With HIV-Related Kaposi's Sarcoma (NCT00064142)National Cancer Institute (NCI)2003-05-01

Track Recurrent Kaposi Sarcoma automatically

Every clearance here is in the API, with alerts when new ones post.